Author: Dr Padman Vamadevan
-
“Turning Data into Confidence”: A Clinician’s Reflection on a Patient’s Journey
Recently, Dale Atkinson, a patient who used Astron’s Extended Precision Oncology Research service, shared a detailed account of his cancer journey. His story captures two difficult realities: With Dale’s permission, I’d like to share his words directly, as they vividly illustrate the patient experience and show how Astron can ease the burden of research and…
-
More Than Standard Precision Oncology: Why Astron’s Approach is Different
Watch the complete presentation above for a detailed look on what makes Astron’s approach different to standard precision oncology processes. The executive summary below covers key points from our video “More Than Standard Precision Oncology: Why Astron’s Approach is Different”, presented by Dr Padman, Chief Medical Officer at Astron Health. Executive Summary Astron Health serves…
-
Why everyone is talking about Extended Precision Oncology
Did you know that standard precision oncology can currently target fewer than 7% of known cancer driver genes? While genomic testing has advanced rapidly, and can now identifying thousands of molecular irregularities within cancer cells1, the development of new precision oncology drugs has not kept pace. That leaves over 93% of these potential targets unexplored.…
-
Astron Health: A Research Organisation Focused on Evidence-Based Adjunctive Therapies Through Repurposing of Existing Medications
In the evolving landscape of cancer treatment, precision medicine has revolutionised our approach to therapy. Yet despite remarkable advances in targeted treatments, patients face critical challenges at multiple stages of their cancer journey. Many confront limited options when standard therapies fail or their cancer develops resistance. Equally concerning are the limited strategies available after curative…
-
Why Personalized Oncology Treatment Matters for Better Patient Outcomes
In the evolving landscape of cancer care, personalized oncology treatment has emerged as a game-changer. Unlike the traditional one-size-fits-all approach, personalized oncology tailors treatment strategies to the unique genetic, molecular, and clinical characteristics of each patient’s cancer. By leveraging advanced molecular testing, multi-omic analyses, and innovative therapeutic strategies, personalized cancer treatments have the potential to…
-
A Smarter Way to Fight Cancer: The Use of Synthetic Lethality for Better Outcomes
In the complex battle against cancer, breakthroughs often emerge from unexpected places. One of the most promising approaches in modern oncology is synthetic lethality—a concept first discovered in 1922 in genetic studies and later applied to cancer treatment in the early 2000s. This powerful approach turns a tumor’s genetic vulnerabilities against itself, offering a novel…
-
Unlocking New Hope in Cancer Treatment: How Astron Health is Changing the Game
For many cancer patients, hearing about concepts like drug repurposing or the metabolic theory of cancer offers a glimmer of hope. These approaches suggest that existing, well-studied medications might help fight cancer in new ways. At Astron Health, we’re turning these promising ideas into reality through rigorous science and personalized medicine. A New Approach to…
-
Innovation vs. Misinformation: How Astron Health Balances Curiosity with Clinical Evidence to Address the Toughest Challenges in Cancer Biology
In an age where medical misinformation spreads faster than peer-reviewed research, trust in healthcare innovation is under siege. While skepticism toward unproven therapies is justified, it’s essential not to conflate scientific exploration with pseudoscience. At Astron Health, we aim to answer some of the most difficult questions in cancer biology—not with conjecture, but through clinical…
Astron Health Blog 